HVIVO
hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker ‘HVO’).
HVIVO
Industry:
Biotechnology Health Care Medical
Founded:
1988-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.hvivo.com
Total Employee:
501+
Status:
Active
Contact:
+44 20 7756 1300
Email Addresses:
[email protected]
Total Funding:
2.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Stock Details
Company's stock symbol is LSE:HVO
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-03-04 | Activiomics | Activiomics acquired by hVIVO | 4 M GBP |
Investors List
Aquarius Equity Partners
Aquarius Equity Partners investment in Series B - hVIVO
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-04-28 | Imutex | hVIVO investment in Seed Round - Imutex | 14 M GBP |
| 2015-11-02 | PrEP Biopharm | hVIVO investment in Series A - PrEP Biopharm | 21 M GBP |
Official Site Inspections
http://www.hvivo.com Semrush global rank: 3.5 M Semrush visits lastest month: 4.26 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 